1. |
Roush SW, Murphy TV, Vaccine-Preventable Disease Table Working Group. Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States[J]. JAMA, 2007, 298(18): 2155-2163. DOI: 10.1001/jama.298.18.2155.
|
2. |
Kuniyoshi K, Hatsukawa Y, Kimura S, et al. Acute bilateral photoreceptor degeneration in an infant after vaccination against measles and rubella[J]. JAMA Ophthalmol, 2017, 135(5): 478-482. DOI: 10.1001/jamaophthalmol.2017.0380.
|
3. |
Fraunfelder FW, Suhler EB, Fraunfelder FT. Hepatitis B vaccine and uveitis: an emerging hypothesis suggested by review of 32 case reports[J]. Cutan Ocul Toxicol, 2010, 29(1): 26-29. DOI: 10.3109/15569520903427717.
|
4. |
Holt HD, Hinkle DM, Falk NS, et al. Human papilloma virus vaccine associated uveitis[J]. Curr Drug Saf, 2014, 9(1): 65-68. DOI: 10.2174/15748863113086660062.
|
5. |
Cunningham ET Jr, Moorthy RS, Fraunfelder FW, et al. Vaccine-associated uveitis[J]. Ocul Immunol Inflamm, 2019, 27(4): 517-520. DOI: 10.1080/09273948.2019.1626188.
|
6. |
Cochrane CG, Koffler D. Immune complex disease in experimental animals and man[J]. Adv Immunol, 1973, 16(0): 185-264. DOI: 10.1016/s0065-2776(08)60298-9.
|
7. |
Watad A, Bragazzi NL, McGonagle D, et al. Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) demonstrates distinct autoimmune and autoinflammatory disease associations according to the adjuvant subtype: insights from an analysis of 500 cases[J]. Clin Immunol, 2019, 203: 1-8. DOI: 10.1016/j.clim.2019.03.007.
|
8. |
Watad A, Quaresma M, Bragazzi NL, et al. The autoimmune/inflammatory syndrome induced by adjuvants (ASIA)/shoenfeld's syndrome: descriptive analysis of 300 patients from the international ASIA syndrome registry[J]. Clin Rheumatol, 2018, 37(2): 483-493. DOI: 10.1007/s10067-017-3748-9.
|
9. |
Reed SG, Orr MT, Fox CB. Key roles of adjuvants in modern vaccines[J]. Nat Med, 2013, 19(12): 1597-1608. DOI: 10.1038/nm.3409.
|
10. |
Pasare C, Medzhitov R. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells[J]. Science, 2003, 299(5609): 1033-1036. DOI: 10.1126/science.1078231.
|
11. |
Khan Z, Combadière C, Authier FJ, et al. Slow CCL2-dependent translocation of biopersistent particles from muscle to brain[J/OL]. BMC Med, 2013, 11: 99[2013-04-04]. https://pubmed.ncbi.nlm.nih.gov/23557144/. DOI: 10.1186/1741-7015-11-99.
|
12. |
Shaw CA, Petrik MS. Aluminum hydroxide injections lead to motor deficits and motor neuron degeneration[J]. J Inorg Biochem, 2009, 103(11): 1555-1562. DOI: 10.1016/j.jinorgbio.2009.05.019.
|
13. |
Gherardi RK, Coquet M, Cherin P, et al. Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle[J]. Brain, 2001, 24(Pt 9): 1821-1831. DOI: 10.1093/brain/124.9.1821.
|
14. |
Karussis D, Petrou P. The spectrum of post-vaccination inflammatory CNS demyelinating syndromes[J]. Autoimmun Rev, 2014, 13(3): 215-224. DOI: 10.1016/j.autrev.2013.10.003.
|
15. |
Cunningham ET Jr, Moorthy RS. Vaccine-associated posterior uveitis[J]. Retina, 2020, 40(4): 595-598. DOI: 10.1097/IAE.0000000000002816.
|
16. |
Ng XL, Betzler BK, Ng S, et al. The eye of the storm: covid-19 vaccination and the eye[J] Ophthalmol Ther, 2021, 11(1): 81-100. DOI: 10.1007/s40123-021-00415-5.
|
17. |
Kniker WT, Cochrane CG. The localization of circulating immune complexes in experimental serum sickness. The role of vasoactive amines and hydrodynamic forces[J]. J Exp Med, 1968, 127(1): 119-136. DOI: 10.1084/jem.127.1.119.
|
18. |
Hylkema HA, Kijlstra A. Circulating immune complexes in uveitis patients[J]. Int Ophthalmol, 1989, 13(4): 253-257. DOI: 10.1007/BF02280084.
|
19. |
Willis ED, Woodward M, Brown E, et al. Herpes zoster vaccine live: a 10 year review of post-marketing safety experience[J]. Vaccine, 2017, 35(52): 7231-7239. DOI: 10.1016/j.vaccine.2017.11.013.
|
20. |
Guex-Crosier Y, Chamot L, Zografos L. Chorioretinitis induced by intravesical bacillus calmette-guérin (BCG) instillations for urinary bladder carcinoma[J]. Klin Monbl Augenheilkd, 2003, 220(3): 193-195. DOI: 10.1055/s-2003-38179.
|
21. |
Llorenç V, Mesquida M, Molins B, et al. Bacillus calmette-guérin infection and cytotoxicity in the retinal pigment epithelium[J]. Ocul Immunol Inflamm, 2018, 26(5): 786-792. DOI: 10.1080/09273948.2016.1265655.
|
22. |
Cusick MF, Libbey JE, Fujinami RS. Molecular mimicry as a mechanism of autoimmune disease[J]. Clin Rev Allergy Immunol, 2012, 42(1): 102-111. DOI: 10.1007/s12016-011-8294-7.
|
23. |
Spratt A, Key T, Vivian AJ. Chronic anterior uveitis following bacille calmette-guérin vaccination: molecular mimicry in action?[J]. J Pediatr Ophthalmol Strabismus, 2008, 45(4): 252-253. DOI: 10.3928/01913913-20080701-15.
|
24. |
Garip A, Diedrichs-Möhring M, Thurau SR, et al. Uveitis in a patient treated with bacille-calmette-guérin: possible antigenic mimicry of mycobacterial and retinal antigens[J]. Ophthalmology, 2009, 116(12): 2457-62. DOI: 10.1016/j.ophtha.2009.05.021.
|
25. |
Furer V, Rondaan C, Heijstek MW, et al. 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases[J]. Ann Rheum Dis, 2020, 79(1): 39-52. DOI: 10.1136/annrheumdis-2019-215882.
|
26. |
Leibowitz JA, Woods AT, Kesselman MM, et al. Uveitis as a predictor of predisposition to autoimmunity[J/OL]. Cureus, 2020, 12(3): e7451[2020-03-28]. https://pubmed.ncbi.nlm.nih.gov/32351830/. DOI: 10.7759/cureus.7451.
|
27. |
Heydari-Kamjani M, Vante I, Uppal P, et al. Uveitis sarcoidosis presumably initiated after administration of shingrix vaccine[J/OL]. Cureus, 2019, 11(6): e4920[2019-06-17]. https://pubmed.ncbi.nlm.nih.gov/31423396/. DOI: 10.7759/cureus.4920.
|
28. |
Singal A, Sonthalia S, Pandhi D. Ulcerated lupus vulgaris at the site of bacille calmette-guérin vaccination[J]. Pediatr Dermatol, 2013, 30(1): 147-148. DOI: 10.1111/j.1525-1470.2011.01607.x.
|
29. |
Farsinejad K, Daneshpazhooh M, Sairafi H, et al. Lupus vulgaris at the site of BCG vaccination: report of three cases[J/OL]. Clin Exp Dermatol, 2009, 34(5): e167-e169[2008-12-15]. https://pubmed.ncbi.nlm.nih.gov/19094126/. DOI: 10.1111/j.1365-2230.2008.03041.x.
|
30. |
Cojocaru M, Cojocaru IM, Silosi I. Multiple autoimmune syndrome[J]. Maedica (Bucur), 2010, 5(2): 132-134.
|
31. |
London WT. Hepatitis B virus and antigen-antibody complex diseases[J]. N Engl J Med, 1977, 296(26): 1528-1529. DOI: 10.1056/NEJM197706302962613.
|
32. |
Moret Ch, Meier P, Rotman S, et al. Fever of unknown origin with granulomatous hepatitis, uveitis and acute renal failure[J]. Praxis (Bern 1994), 2005, 94(1-2): 25-30. DOI: 10.1024/0369-8394.94.1.25.
|
33. |
Farthing CF, Howard RS, Thin RN. Papillitis and hepatitis B[J/OL]. Br Med J (Clin Res Ed), 1986, 292(6537): 1712[1986-06-28]. https://pubmed.ncbi.nlm.nih.gov/3089367/. DOI: 10.1136/bmj.292.6537.1712.
|
34. |
Grob PJ, Martenet AC, Witmer R. Nonspecific immune parameters and hepatitis B antigens in patients with uveitis[J]. Mod Probl Ophthalmol, 1976, 16: 254-258.
|
35. |
Murray PI, Prasad J, Rahi AH. Status of hepatitis B virus in the aetiology of uveitis in great britain[J]. Br J Ophthalmol, 1983, 67(10): 685-687. DOI: 10.1136/bjo.67.10.685.
|
36. |
Benage M, Fraunfelder FW. Vaccine-associated uveitis[J]. Mo Med, 2016, 113(1): 48-52.
|
37. |
Fried M, Conen D, Conzelmann M, et al. Uveitis after hepatitis B vaccination[J]. Lancet, 1987, 2(8559): 631-632. DOI: 10.1016/s0140-6736(87)93027-3.
|
38. |
Ray CL, Dreizin IJ. Bilateral optic neuropathy associated with influenza vaccination[J]. J Neuroophthalmol, 1996, 16(3): 182-184.
|
39. |
Solomon A, Siganos CS, Frucht-Pery J. Adverse ocular effects following influenza vaccination[J]. Eye (Lond), 1999, 13(Pt 3a): 381-382. DOI: 10.1038/eye.1999.101.
|
40. |
Skowronski DM, Strauss B, De Serres G, et al. Oculo-respiratory syndrome: a new influenza vaccine-associated adverse event?[J]. Clin Infect Dis, 2003, 36(6): 705-713. DOI: 10.1086/367667.
|
41. |
Blumberg S, Bienfang D, Kantrowitz FG. A possible association between influenza vaccination and small-vessel vasculitis[J]. Arch Intern Med, 1980, 140(6): 847-848. DOI: 10.1001/archinte.1980.00330180121037.
|
42. |
Dogan B, Erol MK, Cengiz A. Vogt-koyanagi-harada disease following BCG vaccination and tuberculosis[J/OL]. Springerplus, 2016, 5: 603[2016-05-12]. https://pubmed.ncbi.nlm.nih.gov/27247899/. DOI: 10.1186/s40064-016-2223-4.
|
43. |
Ferrini W, Aubert V, Balmer A, et al. Anterior uveitis and cataract after rubella vaccination: a case report of a 12-month-old girl[J/OL]. Pediatrics, 2013, 132(4): e1035-e1038[2013-09-02]. https://pubmed.ncbi.nlm.nih.gov/23999961/. DOI: 10.1542/peds.2012-2930.
|
44. |
Sedaghat M, Zarei-Ghanavati S, Shokoohi S, et al. Panuveitis and dermal vasculitis following MMR vaccination[J]. East Mediterr Health J, 2007, 13(2): 470-474.
|
45. |
Read RW. Uveitis: advances in understanding of pathogenesis and treatment[J]. Curr Rheu-matol Rep, 2006, 8(4): 260-266. DOI: 10.1007/s11926-006-0006-6.
|
46. |
Pasternak J. Vaccine against herpes zoster[J]. Einstein (Sao Paulo), 2013, 11(1): 133-134. DOI: 10.1590/s1679-45082013000100026.
|
47. |
Bharucha T, Ming D, Breuer J. A critical appraisal of 'Shingrix', a novel herpes zoster subunit vaccine (HZ/Su or GSK1437173A) for varicella zoster virus[J]. Hum Vaccin Immunother, 2017, 13(8): 1789-1797. DOI: 10.1080/21645515.2017.1317410.
|
48. |
ElSheikh RH, Haseeb A, Eleiwa TK, et al. Acute uveitis following covid-19 vaccination[J]. Ocul Immunol Inflamm, 2021, 29(6): 1207-1209. DOI: 10.1080/09273948.2021.1962917.
|
49. |
Goyal M, Murthy SI, Annum S. Bilateral multifocal choroiditis following covid-19 vaccination[J]. Ocul Immunol Inflamm, 2021, 29(4): 753-757. DOI: 10.1080/09273948.2021.1957123.
|
50. |
Mudie LI, Zick JD, Dacey MS, et al. Panuveitis following vaccination for covid-19[J]. Ocul Immunol Inflamm, 2021, 29(4): 741-742. DOI: 10.1080/09273948.2021.1949478.
|
51. |
Renisi G, Lombardi A, Stanzione M, et al. Anterior uveitis onset after bnt162b2 vaccination: is this just a coincidence?[J]. Int J Infect Dis, 2021, 110: 95-97. DOI: 10.1016/j.ijid.2021.07.035.
|
52. |
Rabinovitch T, Ben-Arie-Weintrob Y, Hareuveni-Blum T, et al. Uveitis following the BNT162b2 mRNA vaccination against SARS-CoV-2 infection: a possible association[J]. Retina, 2021, 41(12): 2462-2471. DOI: 10.1097/iae.0000000000003277.
|
53. |
Pan L, Zhang Y, Cui Y, et al. Bilateral uveitis after inoculation with covid-19 vaccine: a case report[J]. Int J Infect Dis, 2021, 113: 116-118. DOI: 10.1016/j.ijid.2021.09.075.
|
54. |
Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine[J]. N Engl J Med, 2020, 383(27): 2603-2615. DOI: 10.1056/NEJMoa2034577.
|
55. |
Stangos A, Zaninetti M, Petropoulos I, et al. Multiple evanescent white dot syndrome following simultaneous hepatitis-A and yellow fever vaccination[J]. Ocul Immunol Inflamm, 2006, 14(5): 301-304. DOI: 10.1080/09273940600932311.
|
56. |
Escott S, Tarabishy AB, Davidorf FH. Multifocal choroiditis following simultaneous hepatitis A, typhoid, and yellow fever vaccination[J]. Clin Ophthalmol, 2013, 7: 363-365. DOI: 10.2147/OPTH.S37443.
|
57. |
Baglivo E, Safran AB, Borruat FX. Multiple evanescent white dot syndrome after hepatitis B vaccine[J]. Am J Ophthalmol, 1996, 122(3): 431-432. DOI: 10.1016/s0002-9394(14)72074-4.
|
58. |
Ogino K, Kishi S, Yoshimura N. Multiple evanescent white dot syndrome after human papillomavirus vaccination[J]. Case Rep Ophthalmol, 2014, 5(1): 38-43. DOI: 10.1159/000358870.
|
59. |
Abou-Samra A, Tarabishy AB. Multiple evanescent white dot syndrome following intradermal influenza vaccination[J]. Ocul Immunol Inflamm, 2019, 27(4): 528-530. DOI: 10.1080/09273948.2017.1423334.
|
60. |
Sood AB, O'Keefe G, Bui D, et al. Vogt-koyanagi-harada disease associated with hepatitis B vaccination[J]. Ocul Immunol Inflamm, 2019, 27(4): 524-527. DOI: 10.1080/09273948.2018.1483520.
|
61. |
Saraceno JJF, Souza GM, Dos Santos Finamor LP, et al. Vogt-koyanagi-harada syndrome following covid-19 and ChAdOx1 nCoV-19 (AZD1222) vaccine[J/OL]. Int J Retina Vitreous, 2021, 7(1): 49[2021-08-30]. https://pubmed.ncbi.nlm.nih.gov/34462013/. DOI: 10.1186/s40942-021-00319-3.
|
62. |
Brézin AP, Massin-Korobelnik P, Boudin M, et al. Acute posterior multifocal placoid pigment epitheliopathy after hepatitis B vaccine[J]. Arch Ophthalmol, 1995, 113(3): 297-300. DOI: 10.1001/archopht.1995.01100030051021.
|